Combination therapy with lansoprazole and cholecalciferol is associated with a slower decline in residual beta-cell function and lower insulin requirements in children with recent onset type 1 diabetes: results of a pilot study

Abstract Objective To investigate the effects of combination therapy with cholecalciferol and lansoprazole on residual β-cell function and glycemic control in children with new-onset type 1 diabetes. Methods Children aged 6-12 years with type 1 diabetes were allocated to receive cholecalciferol an...

وصف كامل

التفاصيل البيبلوغرافية

المؤلفون الرئيسيون:	Raghunatha Reddy, Devi Dayal, Naresh Sachdeva, Savita Verma Attri, Vinod Kumar Gupta
التنسيق:	Artigo
اللغة:	Inglês
منشور في:	Instituto Israelita de Ensino e Pesquisa Albert Einstein 2022-11-01
سلاسل:	Einstein (São Paulo)
الموضوعات:	Diabetes mellitus type 1 Blood glucose Glycated hemoglobin A Fasting C-peptide Drug tapering Glycemic control Cholecalciferol Lansoprazole
الوصول للمادة أونلاين:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1679-45082022000100282&tlng=en
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!